生物技术公司CEL-SCI Corp宣布,已与Amarox公司签署一项战略合作协议。该协议的核心内容是,双方将携手在沙特阿拉伯市场推进其免疫治疗药物Multikine的注册审批、商业化运营以及分销网络建设。此举标志着CEL-SCI在中东地区市场拓展迈出了关键一步,旨在加速其创新疗法进入该重要区域。
生物技术公司CEL-SCI Corp宣布,已与Amarox公司签署一项战略合作协议。该协议的核心内容是,双方将携手在沙特阿拉伯市场推进其免疫治疗药物Multikine的注册审批、商业化运营以及分销网络建设。此举标志着CEL-SCI在中东地区市场拓展迈出了关键一步,旨在加速其创新疗法进入该重要区域。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.